Please try another search
For the nine months ended 30 April 2015, Pall Corporation revenues increased 3% to $2.05B. Net income increased 10% to $268.8M. Revenues reflect Life Science segment increase of 3% to $1.08B, Industrial segment increase of 3% to $976.2M, Europe segment increase of 20% to $526.8M, Americas segment increase of 11% to $339.8M. Net income benefited from Life Science segment income increase of 49% to $269.3M.
Period Ending: | Apr 30, 2015 | Jan 31, 2015 | Oct 31, 2014 | Jul 31, 2014 |
---|---|---|---|---|
Total Revenue | 681.14 | 673.79 | 696.49 | 799.95 |
Gross Profit | 355.4 | 341.02 | 361.41 | 408.12 |
Operating Income | 119.56 | 113.19 | 124.73 | 147.93 |
Net Income | 96.18 | 84.4 | 88.27 | 120.09 |
Period Ending: | Apr 30, 2015 | Jan 31, 2015 | Oct 31, 2014 | Jul 31, 2014 |
---|---|---|---|---|
Total Assets | 3740.37 | 3667.91 | 3775.53 | 3850.48 |
Total Liabilities | 2105.82 | 2117.78 | 2180.69 | 1955.12 |
Total Equity | 1634.56 | 1550.13 | 1594.84 | 1895.36 |
Period Ending: | Apr 30, 2015 | Jan 31, 2015 | Oct 31, 2014 | Jul 31, 2014 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | 360.4 | 238.17 | 114.54 | 503.91 |
Cash From Investing Activities | -56.29 | -26.94 | -10.28 | -393.51 |
Cash From Financing Activities | -89.5 | -59.68 | -29.72 | -92.91 |
Net Change in Cash | 130.39 | 65.56 | 37.37 | 27.22 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review